{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:13:44Z","timestamp":1777018424583,"version":"3.51.4"},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Most patients receiving dialysis have other common chronic conditions in addition to end\u2010stage renal disease, including hypertension, diabetes, cardiovascular disease, and mineral and bone disorder, all of which require long\u2010term medication management. Dialysis patients take an average of 10\u201312 prescribed and over\u2010the\u2010counter medications from an average of 4.7 prescribers, and an average of 19 pills per day. Thus, reducing polypharmacy is not adequate as a medication therapy goal for these patients. Instead, the dialysis community should focus on ensuring that all patients receive medications that are appropriate, effective, safe and convenient. Barriers to this include a fragmented health care system with inadequate communication between multiple prescribers and pharmacies, and frequent care transitions between ambulatory care sites (dialysis centre, ambulatory primary care practice, ambulatory specialty practice) and the hospital, skilled nursing facility or long\u2010term care facility. Three distinct processes are necessary to prevent and solve the resultant medication\u2010related problems (and reduce polypharmacy). These are medication reconciliation (creating an accurate medication list that reflects all medications the patients is taking and how they are being taken), medication review (evaluating the list for appropriateness, effectiveness, safety and convenience in conjunction with the patient's health status), and ongoing patient\u2010centred medication therapy management (e.g., developing treatment plans centred on each patient's medication\u2010related goals). A team approach including pharmacists as part of the dialysis team with the dialysis facility as the primary medication home is needed.<\/jats:p>","DOI":"10.1111\/sdi.12377","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T06:37:17Z","timestamp":1428561437000},"page":"427-432","source":"Crossref","is-referenced-by-count":66,"title":["Management of Polypharmacy in Dialysis Patients"],"prefix":"10.1111","volume":"28","author":[{"given":"Wendy L.","family":"St. Peter","sequence":"first","affiliation":[{"name":"College of Pharmacy University of Minnesota Minneapolis Minnesota"},{"name":"Chronic Disease Research Group Minneapolis Medical Research Foundation Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2007.12.002"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f7033"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800303"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50048"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00290109"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01420213"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.04.021"},{"key":"e_1_2_6_9_1","unstructured":"Center for Medicare Advocacy:Part D\/Prescription Drug Benefits. Available athttp:\/\/www.medicareadvocacy.org\/medicare-info\/medicare-part-d\/#covered%20drugs accessed September 29 2014"},{"key":"e_1_2_6_10_1","unstructured":"The Henry J. Kaiser Family Foundation:Medicare Part D in It's Ninth Year: The 2014 Marketplace and Key Trends 2006\u20132014. Available athttp:\/\/kff.org\/medicare\/report\/medicare-part-d-in-its-ninth-year-the-2014-marketplace-and-key-trends-2006-2014\/ accessed September 29 2014"},{"key":"e_1_2_6_11_1","volume-title":"USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease & End\u2010Stage Renal Disease in the United States","author":"U.S. Renal Data System","year":"2013"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.8.862"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v31.pm9531172"},{"issue":"31","key":"e_1_2_6_14_1","first-page":"34","article-title":"Comparison of preventive care provided to dialysis patients by nephrologists and to patients followed in general medical clinics: compliance with American College of Physicians Guidelines","author":"Hamad A","year":"2002","journal-title":"Hemodial Int"},{"key":"e_1_2_6_15_1","unstructured":"Centers for Medicare & Medicaid Services:Eligible Professional Meaningful Use Menu Set Measures Measure 6 of 9. Available athttp:\/\/www.cms.gov\/Regulations-and-Guidance\/Legislation\/EHRIncentivePrograms\/downloads\/7_Medication_Reconciliation.pdf accessed September 29 2014"},{"issue":"5","key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4212\/cjhp.v62i5.826","article-title":"Best possible medication history for hemodialysis patients obtained by a pharmacy technician","volume":"62","author":"Leung M","year":"2009","journal-title":"Can J Hosp Pharm"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.2.231.32079"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G482"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02010408"},{"key":"e_1_2_6_20_1","unstructured":"HorneR WeinmanJ BarberH ElliotR MorganM:Concordance adherence and compliance in medicine taking. Report for the National Co\u2010ordinating Centre for NHS Service Delivery and Organisation R & D. December 2005. Available athttp:\/\/www.nets.nihr.ac.uk\/__data\/assets\/pdf_file\/0007\/81394\/ES-08-1412-076.pdf accessed September 29 2014"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2010.06.001"},{"key":"e_1_2_6_22_1","unstructured":"U.S. Department of Health and Human Services (HHS):AHRQ Medication Reconciliation. Available athttp:\/\/healthit.ahrq.gov\/ahrq-funded-projects\/emerging-lessons\/medication-reconciliation accessed September 29 2014"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2834.2009.00995.x"},{"issue":"15","key":"e_1_2_6_24_1","first-page":"106","article-title":"Evaluation of drug history program","volume":"47","author":"La VS","year":"1973","journal-title":"Hospitals"},{"issue":"12","key":"e_1_2_6_25_1","first-page":"964","article-title":"Evaluation of a patient\u2010completed versus health professional\u2010conducted medication history","volume":"22","author":"Montpetit LM","year":"1988","journal-title":"Drug Intell Clin Pharm"},{"issue":"17","key":"e_1_2_6_26_1","first-page":"93","article-title":"Pharmacist, nurse cooperate in taking drug histories","volume":"50","author":"Barger RC","year":"1976","journal-title":"Hospitals"},{"key":"e_1_2_6_27_1","unstructured":"ASHP Pharmacists Advancing Healthcare:American Society of Health\u2010Systems Pharmacy Medication Reconciliation Toolkit. Available athttp:\/\/www.ashp.org\/menu\/PracticePolicy\/ResourceCenters\/PatientSafety\/ASHPMedicationReconciliationToolkit_1.aspx. Accessed September 29 2014"},{"key":"e_1_2_6_28_1","unstructured":"Centers for Medicare and Medicaid Services:Conditions for Coverage for End\u2010Stage Renal Disease Facilities: Final Rule.2013. Available athttp:\/\/www.cms.gov\/Regulations-and-Guidance\/Legislation\/CFCsAndCoPs\/downloads\/\/esrdfinalrule0415.pdf accessed September 29 2014"},{"key":"e_1_2_6_29_1","unstructured":"Medication Therapy Management Services:Definition and Program Criteria 2014. Available athttp:\/\/www.accp.com\/docs\/positions\/misc\/MTMDefn.pdf accessed September 29 2014"},{"key":"e_1_2_6_30_1","unstructured":"Centers for Medicare & Medicaid Services:2015 Medication Therapy Management Program Guidance and Submission Instructions 2014. Available athttp:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/Downloads\/MemoContractYear2015MedicationTherapyManagementProgramSubmission050714.pdf accessed September 29 2014"},{"key":"e_1_2_6_31_1","unstructured":"Centers for Medicare & Medicaid Services:2014 Plan MTM Program Eligibility Information 2014. Available athttp:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/MTM.html accessed September 29 2014"},{"key":"e_1_2_6_32_1","unstructured":"Nephrology News and Issues:Large dialysis companies still have questions about ESCO demo 2014. Available athttp:\/\/www.nephrologynews.com\/articles\/110399-large-dialysis-companies-still-have-questions-about-esco-demo accessed September 29 2014"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6549"},{"issue":"2","key":"e_1_2_6_34_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1331\/JAPhA.2008.07108","article-title":"Clinical and economic outcomes of medication therapy management services: the Minnesota experience","volume":"48","author":"Isetts BJ","year":"2003","journal-title":"J Am Pharm Assoc"},{"key":"e_1_2_6_35_1","unstructured":"Centers for Medicare and Medicaid Services:Medication Therapy Management in Chronically Ill Populations: Final Report. Available athttp:\/\/innovation.cms.gov\/Files\/reports\/MTM_Final_Report.pdf accessed September 29 2014"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.02.360"},{"key":"e_1_2_6_37_1","unstructured":"WeinhandlED YusufA PengY St. PeterWL:Opioid analgestic use among dialysis patients. Poster session presented at American Society of Nephrology Conference Atlanta GA November 5\u201310 2013"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.09.008"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2013.0542"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fsdi.12377","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/sdi.12377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T01:52:33Z","timestamp":1747878753000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/sdi.12377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1111\/sdi.12377"],"URL":"https:\/\/doi.org\/10.1111\/sdi.12377","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]}}}